BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15729966)

  • 1. The use of albumin in patients with decompensated cirrhosis: the case in favor.
    Maor Y
    Isr Med Assoc J; 2005 Feb; 7(2):115-8. PubMed ID: 15729966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of albumin in all patients with decompensated cirrhosis is not justified.
    Avidan B
    Isr Med Assoc J; 2005 Feb; 7(2):118-20. PubMed ID: 15729967
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical indications for the albumin use: still a controversial issue.
    Caraceni P; Domenicali M; Tovoli A; Napoli L; Ricci CS; Tufoni M; Bernardi M
    Eur J Intern Med; 2013 Dec; 24(8):721-8. PubMed ID: 23790570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of albumin infusion in decompensated liver cirrhosis].
    Schmidt LE; Ring-Larsen H
    Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intravenous albumin administration in hypoalbuminemic patients: why and when.
    Bernheim J
    Isr Med Assoc J; 2005 Feb; 7(2):113-5. PubMed ID: 15729965
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
    Zaak D; Paquet KJ; Kuhn R
    Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoalbuminemia.
    Gatta A; Verardo A; Bolognesi M
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S193-9. PubMed ID: 23073857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
    Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascites and spontaneous bacterial peritonitis: an Asian perspective.
    Lee JM; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1494-503. PubMed ID: 19743995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
    Singh V; Kumar B; Nain CK; Singh B; Sharma N; Bhalla A; Sharma AK
    J Intern Med; 2006 Jul; 260(1):62-8. PubMed ID: 16789980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascites in cirrhosis: a review of management and complications.
    Kuiper JJ; van Buuren HR; de Man RA
    Neth J Med; 2007 Sep; 65(8):283-8. PubMed ID: 17890787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of ascites. A review.
    Watanabe A
    J Med; 1997; 28(1-2):21-30. PubMed ID: 9249607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug insight: the role of albumin in the management of chronic liver disease.
    Wong F
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jan; 4(1):43-51. PubMed ID: 17203088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
    Singh V; Kumar R; Nain CK; Singh B; Sharma AK
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical application of albumin: a closer look at indications].
    Smorenburg CH; ter Wee PM; Gans RO
    Ned Tijdschr Geneeskd; 1997 Apr; 141(15):719-23. PubMed ID: 9213788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin infusion in liver cirrhotic patients.
    Rena NM; Wibawa ID
    Acta Med Indones; 2010 Jul; 42(3):162-8. PubMed ID: 20724771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.